Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Polyphenon E
100%
Chemoprevention
100%
Colorectal Cancer
100%
Aberrant Crypt Foci
100%
Green Tea Polyphenols
25%
Epigallocatechin-3-gallate
16%
High Risk
16%
Rodents
16%
Colorectal Cancer Risk
16%
Colon Cancer
16%
Adenoma
16%
Chemoprevention Trial
16%
Magnifying Chromoendoscopy
16%
Chemopreventive
16%
Surrogate Endpoint Biomarker
16%
Colon Adenocarcinoma
8%
Consumption Risk
8%
Colorectal Neoplasms
8%
COX Inhibitors
8%
Japan
8%
Polyphenols
8%
Drug Levels
8%
Rectum
8%
Dysplastic Foci
8%
Risk Reduction
8%
Carcinogenesis Models
8%
High-grade Dysplasia
8%
Carcinoma
8%
Histopathology
8%
Short-term Administration
8%
Azoxymethane
8%
Cancer Preventive
8%
Carcinogen-induced
8%
Animal Model System
8%
Adenomatous Polyps
8%
Rodent Models
8%
Normal mucosa
8%
Human Cancer
8%
Colon Surgery
8%
Placebo
8%
Clinical High Risk
8%
Human Studies
8%
Study Support
8%
Percent Change
8%
Caffeine
8%
Epidemiologic Studies
8%
CRC Risk
8%
Precursor Lesions
8%
Open-label Trial
8%
Green Tea Consumption
8%
Randomized Phase II Trial
8%
Crypt
8%
Preclinical Data
8%
Colorectal mucosa
8%
Sulindac
8%
Green Tea
8%
Non-selective
8%
Tissue Biomarkers
8%
Focusing Characteristics
8%
Colorectal Adenoma
8%
Mechanistic Insights
8%
Pharmacology, Toxicology and Pharmaceutical Science
Polyphenon E
100%
Aberrant Crypt Foci
100%
Colorectal Carcinoma
100%
Polyphenol
33%
Colon Carcinoma
25%
Biological Marker
25%
Epigallocatechin Gallate
16%
Adenoma
16%
Colorectal Tumor
8%
Colon Carcinogenesis
8%
Carcinoma
8%
Chemopreventive Agents
8%
Adenomatous Polyp
8%
Azoxymethane
8%
Dysplasia
8%
Preclinical Study
8%
Open-Label Trial
8%
Observational Study
8%
Carcinogen
8%
Colorectal Adenoma
8%
Malignant Neoplasm
8%
Placebo
8%
Carcinogenesis
8%
Human Study
8%
Sulindac
8%